Assessment of myocardial fibrosis by endoventricular electromechanical mapping in experimental nonischemic cardiomyopathy

Peter J. Psaltis, Angelo Carbone, Darryl P. Leong, Dennis H. Lau, Adam J. Nelson, Tim Kuchel, Troy Jantzen, Jim Manavis, Kerry Williams, Prashanthan Sanders, Stan Gronthos, Andrew C W Zannettino, Stephen G. Worthley

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Cardiac fibrosis plays an important prognostic role in nonischemic cardiomyopathy (NICM), making it a potential therapeutic target. Although electromechanical mapping has been used to identify myocardial scar and facilitate intramyocardial intervention in the setting of ischemic heart disease, its application has not been described in NICM. We assessed the detection of myocardial fibrosis by endoventricular electromechanical mapping in an experimental model of NICM. The NOGA® XP system was used to perform left ventricular mapping in twelve sheep that had undergone intracoronary doxorubicin dosing to induce NICM and in six healthy control animals. Results for endocardial voltage and mechanical shortening were evaluated against myocardial fibrosis burden, as determined by delayed-enhancement cardiac magnetic resonance and quantitative histomorphometry. Doxorubicin treatment resulted in dilated cardiomyopathy with moderate-severe impairment of left ventricular ejection fraction. Late gadolinium uptake was present in 9/12 doxorubicin animals, while histological fibrosis was approximately doubled compared to controls and was distributed multisegmentally throughout the left ventricle. Cardiomyopathy was associated with widespread reductions in unipolar and bipolar voltage amplitude and endocardial shortening. Each parameter showed an inverse relationship with the burden of fibrosis. Moreover, unipolar voltage and linear local shortening ratio displayed moderate accuracy for identifying myocardial segments with delayed contrast enhancement or increased fibrosis content, with optimal discriminatory thresholds of 7.5 mV and 11.5%, respectively. In this model of NICM, electromechanical mapping shows potential for delineating segmental differences in fibrosis. Pending clinical evaluation, it may therefore have applicability for directing targeted intramyocardial interventions in nonischemic heart disease.

LanguageEnglish
Pages25-37
Number of pages13
JournalInternational Journal of Cardiovascular Imaging
Volume27
Issue number1
DOIs
Publication statusPublished - 1 Jan 2011

Keywords

  • Animal models
  • Cardiac fibrosis
  • Cardiac remodeling
  • Mapping
  • NOGA
  • Nonischemic cardiomyopathy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Psaltis, Peter J. ; Carbone, Angelo ; Leong, Darryl P. ; Lau, Dennis H. ; Nelson, Adam J. ; Kuchel, Tim ; Jantzen, Troy ; Manavis, Jim ; Williams, Kerry ; Sanders, Prashanthan ; Gronthos, Stan ; Zannettino, Andrew C W ; Worthley, Stephen G. / Assessment of myocardial fibrosis by endoventricular electromechanical mapping in experimental nonischemic cardiomyopathy. In: International Journal of Cardiovascular Imaging. 2011 ; Vol. 27, No. 1. pp. 25-37.
@article{b33f75581e79485cba2defe45ab91b96,
title = "Assessment of myocardial fibrosis by endoventricular electromechanical mapping in experimental nonischemic cardiomyopathy",
abstract = "Cardiac fibrosis plays an important prognostic role in nonischemic cardiomyopathy (NICM), making it a potential therapeutic target. Although electromechanical mapping has been used to identify myocardial scar and facilitate intramyocardial intervention in the setting of ischemic heart disease, its application has not been described in NICM. We assessed the detection of myocardial fibrosis by endoventricular electromechanical mapping in an experimental model of NICM. The NOGA{\circledR} XP system was used to perform left ventricular mapping in twelve sheep that had undergone intracoronary doxorubicin dosing to induce NICM and in six healthy control animals. Results for endocardial voltage and mechanical shortening were evaluated against myocardial fibrosis burden, as determined by delayed-enhancement cardiac magnetic resonance and quantitative histomorphometry. Doxorubicin treatment resulted in dilated cardiomyopathy with moderate-severe impairment of left ventricular ejection fraction. Late gadolinium uptake was present in 9/12 doxorubicin animals, while histological fibrosis was approximately doubled compared to controls and was distributed multisegmentally throughout the left ventricle. Cardiomyopathy was associated with widespread reductions in unipolar and bipolar voltage amplitude and endocardial shortening. Each parameter showed an inverse relationship with the burden of fibrosis. Moreover, unipolar voltage and linear local shortening ratio displayed moderate accuracy for identifying myocardial segments with delayed contrast enhancement or increased fibrosis content, with optimal discriminatory thresholds of 7.5 mV and 11.5{\%}, respectively. In this model of NICM, electromechanical mapping shows potential for delineating segmental differences in fibrosis. Pending clinical evaluation, it may therefore have applicability for directing targeted intramyocardial interventions in nonischemic heart disease.",
keywords = "Animal models, Cardiac fibrosis, Cardiac remodeling, Mapping, NOGA, Nonischemic cardiomyopathy",
author = "Psaltis, {Peter J.} and Angelo Carbone and Leong, {Darryl P.} and Lau, {Dennis H.} and Nelson, {Adam J.} and Tim Kuchel and Troy Jantzen and Jim Manavis and Kerry Williams and Prashanthan Sanders and Stan Gronthos and Zannettino, {Andrew C W} and Worthley, {Stephen G.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1007/s10554-010-9657-5",
language = "English",
volume = "27",
pages = "25--37",
journal = "International Journal of Cardiovascular Imaging",
issn = "1569-5794",
publisher = "Springer Netherlands",
number = "1",

}

Assessment of myocardial fibrosis by endoventricular electromechanical mapping in experimental nonischemic cardiomyopathy. / Psaltis, Peter J.; Carbone, Angelo; Leong, Darryl P.; Lau, Dennis H.; Nelson, Adam J.; Kuchel, Tim; Jantzen, Troy; Manavis, Jim; Williams, Kerry; Sanders, Prashanthan; Gronthos, Stan; Zannettino, Andrew C W; Worthley, Stephen G.

In: International Journal of Cardiovascular Imaging, Vol. 27, No. 1, 01.01.2011, p. 25-37.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Assessment of myocardial fibrosis by endoventricular electromechanical mapping in experimental nonischemic cardiomyopathy

AU - Psaltis, Peter J.

AU - Carbone, Angelo

AU - Leong, Darryl P.

AU - Lau, Dennis H.

AU - Nelson, Adam J.

AU - Kuchel, Tim

AU - Jantzen, Troy

AU - Manavis, Jim

AU - Williams, Kerry

AU - Sanders, Prashanthan

AU - Gronthos, Stan

AU - Zannettino, Andrew C W

AU - Worthley, Stephen G.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Cardiac fibrosis plays an important prognostic role in nonischemic cardiomyopathy (NICM), making it a potential therapeutic target. Although electromechanical mapping has been used to identify myocardial scar and facilitate intramyocardial intervention in the setting of ischemic heart disease, its application has not been described in NICM. We assessed the detection of myocardial fibrosis by endoventricular electromechanical mapping in an experimental model of NICM. The NOGA® XP system was used to perform left ventricular mapping in twelve sheep that had undergone intracoronary doxorubicin dosing to induce NICM and in six healthy control animals. Results for endocardial voltage and mechanical shortening were evaluated against myocardial fibrosis burden, as determined by delayed-enhancement cardiac magnetic resonance and quantitative histomorphometry. Doxorubicin treatment resulted in dilated cardiomyopathy with moderate-severe impairment of left ventricular ejection fraction. Late gadolinium uptake was present in 9/12 doxorubicin animals, while histological fibrosis was approximately doubled compared to controls and was distributed multisegmentally throughout the left ventricle. Cardiomyopathy was associated with widespread reductions in unipolar and bipolar voltage amplitude and endocardial shortening. Each parameter showed an inverse relationship with the burden of fibrosis. Moreover, unipolar voltage and linear local shortening ratio displayed moderate accuracy for identifying myocardial segments with delayed contrast enhancement or increased fibrosis content, with optimal discriminatory thresholds of 7.5 mV and 11.5%, respectively. In this model of NICM, electromechanical mapping shows potential for delineating segmental differences in fibrosis. Pending clinical evaluation, it may therefore have applicability for directing targeted intramyocardial interventions in nonischemic heart disease.

AB - Cardiac fibrosis plays an important prognostic role in nonischemic cardiomyopathy (NICM), making it a potential therapeutic target. Although electromechanical mapping has been used to identify myocardial scar and facilitate intramyocardial intervention in the setting of ischemic heart disease, its application has not been described in NICM. We assessed the detection of myocardial fibrosis by endoventricular electromechanical mapping in an experimental model of NICM. The NOGA® XP system was used to perform left ventricular mapping in twelve sheep that had undergone intracoronary doxorubicin dosing to induce NICM and in six healthy control animals. Results for endocardial voltage and mechanical shortening were evaluated against myocardial fibrosis burden, as determined by delayed-enhancement cardiac magnetic resonance and quantitative histomorphometry. Doxorubicin treatment resulted in dilated cardiomyopathy with moderate-severe impairment of left ventricular ejection fraction. Late gadolinium uptake was present in 9/12 doxorubicin animals, while histological fibrosis was approximately doubled compared to controls and was distributed multisegmentally throughout the left ventricle. Cardiomyopathy was associated with widespread reductions in unipolar and bipolar voltage amplitude and endocardial shortening. Each parameter showed an inverse relationship with the burden of fibrosis. Moreover, unipolar voltage and linear local shortening ratio displayed moderate accuracy for identifying myocardial segments with delayed contrast enhancement or increased fibrosis content, with optimal discriminatory thresholds of 7.5 mV and 11.5%, respectively. In this model of NICM, electromechanical mapping shows potential for delineating segmental differences in fibrosis. Pending clinical evaluation, it may therefore have applicability for directing targeted intramyocardial interventions in nonischemic heart disease.

KW - Animal models

KW - Cardiac fibrosis

KW - Cardiac remodeling

KW - Mapping

KW - NOGA

KW - Nonischemic cardiomyopathy

UR - http://www.scopus.com/inward/record.url?scp=79951855157&partnerID=8YFLogxK

U2 - 10.1007/s10554-010-9657-5

DO - 10.1007/s10554-010-9657-5

M3 - Article

VL - 27

SP - 25

EP - 37

JO - International Journal of Cardiovascular Imaging

T2 - International Journal of Cardiovascular Imaging

JF - International Journal of Cardiovascular Imaging

SN - 1569-5794

IS - 1

ER -